Concepedia

J. Porter

JP

Statistics

Publications

19

Citations

591

H-Index

16

Active since

1975

Affiliations

Institute for Clinical Evaluative Sciences(Current)

University of Toronto

University College Cork

Sunnybrook Health Science Centre

McMaster University

J. Porter is an author at Institute for Clinical Evaluative Sciences specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1975–2015

19

Publications

19

A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.

J. Scott Mohrland, J. Porter, Elizabeth A. Smith et al. · Annals of the Rheumatic Diseases · 1985 · 78 citations · Full text

, , +13

Health System Costs for Stage-Specific Breast Cancer: A Population-Based Approach

Nicole Mittmann, J. Porter, J. Rangrej et al. · Current Oncology · 2014 · 69 citations · Full text

, , +16

Inhibition of neutrophil apoptosis after elective surgery

Noel Fanning, J. Porter, George Shorten et al. · Surgery · 1999 · 60 citations

, , +14

Needle placement and injection posterior to the axillary artery may predict successful infraclavicular brachial plexus block: a report of three cases

J. Porter, Colin J. L. McCartney, Vincent Chan · Canadian Journal of Anesthesia/Journal canadien d anesthésie · 2005 · 51 citations · Full text

, , +5

A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment

Christopher J. Sweeney, Chris H. Takimoto, Leslie Wood et al. · Cancer Chemotherapy and Pharmacology · 2009 · 34 citations

, , +10

1–5 of 19